ARCHIVES

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

This article is from The Cancer Letter archive.

Vol. 22 No. 14 | April 4, 1996

Download PDF Visit The Full Archive

Related Articles

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Moddelmog Steps Down At Komen For the Cure

November 20, 2009